IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nurix Therapeutics Inc

CUSIP: SBMVLGP25 | 1 institutional holders

Quarters

Q1 2023Q2 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2023

Metropolitan Life Insurance Co2,703
0.0% of portfolio›$24.0K
StyleTurnoverLocationFiled
Metropolitan Life Insurance Co
2,703$24.0K0.0%ETFVery LowNew York, NY2023-05-15